IP Verse

Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof - EP2651400

PATENT ANALYSIS

Patent Details

Grant Date
Jan 18, 2023
Company
AMGEN (EUROPE) GMBH
Oppositions

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Amgen (Europe) Gmbh

EP2651400

EP3320902

EP2797581

Want to monitor this patent?

Feel free to send us a message here and we will get back to you